Premium
Diabetes drug may activate molecule that triggers cancer growth
Author(s) -
Printz Carrie
Publication year - 2014
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28752
Subject(s) - metformin , ampk , medicine , cancer , clinical trial , pi3k/akt/mtor pathway , cancer cell , drug , cancer research , cell growth , diabetes mellitus , pharmacology , oncology , bioinformatics , protein kinase a , kinase , signal transduction , endocrinology , biology , microbiology and biotechnology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom